Two-in-one aortic valve sizing and valvuloplasty conductance balloon catheter
Background Inaccurate aortic valve sizing and selection is linked to paravalvular leakage in transcatheter aortic valve replacement (TAVR). Here, a novel sizing valvuloplasty conductance balloon (SVCB) catheter is shown to be accurate, reproducible, unbiased, and provides real‐time tool for aortic v...
Saved in:
Published in | Catheterization and cardiovascular interventions Vol. 86; no. 1; pp. 136 - 143 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.07.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Inaccurate aortic valve sizing and selection is linked to paravalvular leakage in transcatheter aortic valve replacement (TAVR). Here, a novel sizing valvuloplasty conductance balloon (SVCB) catheter is shown to be accurate, reproducible, unbiased, and provides real‐time tool for aortic valve sizing that fits within the standard valvuloplasty procedure.
Methods and Results
The SVCB catheter is a valvuloplasty device that uses real‐time electrical conductance measurements based on Ohm's Law to size the balloon opposed against the aortic valve at any given inflation pressure. Accuracy and repeatability of the SVCB catheter was performed on the bench in phantoms of known dimension and ex vivo in three domestic swine aortic annuli with comparison to computed tomography (CT) and dilator measurements. Procedural workflow and safety was demonstrated in vivo in three additional domestic swine. SVCB catheter measurements had negligible bias or error for bench accuracy considered as the gold standard (Bias: −0.11 ± 0.26 mm; Error: 1.2%), but greater disagreement in ex vivo versus dilators (Bias: −0.3 ± 1.1 mm; Error: 4.5%), and ex vivo versus CT (Bias: −1.0 ± 1.6 mm; Error: 8.7%). The dilator versus CT accuracy showed similar agreement (Bias: −0.9 ± 1.5 mm; Error: 7.3%). Repeatability was excellent on the bench (Bias: 0.02 ± 0.12 mm; Error: 0.5%) and ex vivo (Bias: −0.4 ± 0.9 mm; Error: 4.6%). In animal studies, the device fit well within the procedural workflow with no adverse events or complications.
Conclusions
Due to the clinical relevance of this accurate, repeatable, unbiased, and real‐time sizing measurement, the SVCB catheter may provide a useful tool prior to TAVR. These findings merit a future human study. © 2015 Wiley Periodicals, Inc. |
---|---|
Bibliography: | istex:B1B44E649BC9BEDF0C07953EC2343CC16051F12F ark:/67375/WNG-4SWBT0SL-2 ArticleID:CCD25774 Disclosures: Drs. Svendsen, Babalarios, and Berwick have received compensation from 3DT. Dr. Kassab is the founder of 3DT. Conflict of interest: Nothing to report. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1522-1946 1522-726X |
DOI: | 10.1002/ccd.25774 |